← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2019Last known activity
Jan 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT05985850Reponsible party - principal investigatorPhase 2Jan 31, 2024
- NCT05985850Lead sponsorPhase 2Jan 31, 2024
- NCT04815590Lead sponsorPhase 4Apr 15, 2021
- NCT04815590Sponsor investigatorPhase 4Apr 15, 2021
- NCT03948464Overall official - principal investigatorPhase 3Jul 1, 2019
- NCT03948464Sponsor investigatorPhase 3Jul 1, 2019
- NCT03948464Lead sponsorPhase 3Jul 1, 2019
Details
- Last known activity
- Jan 31, 2024